- PCSK9 and the Gut-Liver-Brain Axis: A Novel Therapeutic Target for Immune Regulation in Alcohol Use Disorder
Ji Soo Lee et al, 2021, Journal of Clinical Medicine CrossRef - A Comprehensive Review on PCSK9 as Mechanistic Target Approach in Cancer Therapy
Sudipta Saha et al, 2023, Mini-Reviews in Medicinal Chemistry CrossRef - PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease
Bianca Papotti et al, 2022, International Journal of Molecular Sciences CrossRef - Protective Mechanism of Proprotein Convertase Subtilisin-Like Kexin Type 9 Inhibitor on Rats with Middle Cerebral Artery Occlusion-Induced Cerebral Ischemic Infarction
Shengxiong Pu et al, 2022, Computational Intelligence and Neuroscience CrossRef - Coming Back to Physiology: Extra Hepatic Functions of Proprotein Convertase Subtilisin/Kexin Type 9
Klaus-Dieter Schlüter et al, 2020, Frontiers in Physiology CrossRef - Proprotein Convertase Subtilisin/Kexin Type 9, Brain Cholesterol Homeostasis and Potential Implication for Alzheimer’s Disease
Maria Pia Adorni et al, 2019, Frontiers in Aging Neuroscience CrossRef - Case Report: Neurological adverse events in subject with myasthenia gravis after PCSK9 inhibitor administration
Věra Adámková et al, 2024, Frontiers in Cardiovascular Medicine CrossRef - Surfeit Locus Protein 4 as a Novel Target for Therapeutic Intervention in Cerebral Ischemia–Reperfusion Injury
Wenjie Hu et al, 2024, Molecular Neurobiology CrossRef - Sex-Specific Association of Endogenous PCSK9 With Memory Function in Elderly Subjects at High Cardiovascular Risk
Paola G. Simeone et al, 2021, Frontiers in Aging Neuroscience CrossRef - Targeted Antitumor Mechanism of C-PC/CMC-CD55sp Nanospheres in HeLa Cervical Cancer Cells
Guoxiang Liu et al, 2020, Frontiers in Pharmacology CrossRef - The Emerging Roles of Intracellular PCSK9 and Their Implications in Endoplasmic Reticulum Stress and Metabolic Diseases
Paul F. Lebeau et al, 2022, Metabolites CrossRef